475 related articles for article (PubMed ID: 18850478)
41. [Value of cardiac troponin I measurement in prediction of anthracycline-induced cardiotoxicity in breast cancer patients].
Huang WB; Yao GY; Liu MF; Chen RT; Chen LJ; Dong JY; Gu F; Guo ZZ; Ye CS
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(6):1047-50. PubMed ID: 21690066
[TBL] [Abstract][Full Text] [Related]
42. Anthracycline-induced cardiotoxicity: comparison of recommendations for monitoring cardiac function during therapy in paediatric oncology trials.
van Dalen EC; van den Brug M; Caron HN; Kremer LC
Eur J Cancer; 2006 Dec; 42(18):3199-205. PubMed ID: 17011186
[TBL] [Abstract][Full Text] [Related]
43. Monitoring of anthracycline-induced cardiotoxicity.
Jannazzo A; Hoffman J; Lutz M
Ann Pharmacother; 2008 Jan; 42(1):99-104. PubMed ID: 18094345
[TBL] [Abstract][Full Text] [Related]
44. Brain natriuretic peptide as a cardiotoxicity biomarker in children with hematological malignancies.
Tragiannidis A; Dokos C; Tsotoulidou V; Giannopoulos A; Pana ZD; Papageorgiou T; Karamouzis M; Athanassiadou F
Minerva Pediatr; 2012 Jun; 64(3):307-12. PubMed ID: 22555323
[TBL] [Abstract][Full Text] [Related]
45. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
[TBL] [Abstract][Full Text] [Related]
46. Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity.
Okumura H; Iuchi K; Yoshida T; Nakamura S; Takeshima M; Takamatsu H; Ikeno A; Usuda K; Ishikawa T; Ohtake S; Matsuda T
Acta Haematol; 2000; 104(4):158-63. PubMed ID: 11279304
[TBL] [Abstract][Full Text] [Related]
47. Cardiac troponin I seems to be superior to cardiac troponin T in the early detection of cardiac injury associated with anthracycline treatment.
Horacek JM; Pudil R; Tichy M; Jebavy L; Strasova A; Ulrychova M; Zak P; Maly J
Onkologie; 2008 Oct; 31(10):559-60. PubMed ID: 18854658
[No Abstract] [Full Text] [Related]
48. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
[TBL] [Abstract][Full Text] [Related]
49. Role of biomarkers in chemotherapy-induced cardiotoxicity.
Cardinale D; Sandri MT
Prog Cardiovasc Dis; 2010; 53(2):121-9. PubMed ID: 20728699
[TBL] [Abstract][Full Text] [Related]
50. Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy.
Blaes AH; Rehman A; Vock DM; Luo X; Menge M; Yee D; Missov E; Duprez D
Vasc Health Risk Manag; 2015; 11():591-4. PubMed ID: 26648730
[TBL] [Abstract][Full Text] [Related]
51. Predisposing factors and consequences of elevated biomarker levels in long-distance runners aged >or=55 years.
Sahlén A; Gustafsson TP; Svensson JE; Marklund T; Winter R; Linde C; Braunschweig F
Am J Cardiol; 2009 Nov; 104(10):1434-40. PubMed ID: 19892064
[TBL] [Abstract][Full Text] [Related]
52. Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: a systematic review.
Bryant J; Picot J; Baxter L; Levitt G; Sullivan I; Clegg A
Eur J Cancer; 2007 Sep; 43(13):1959-66. PubMed ID: 17689066
[TBL] [Abstract][Full Text] [Related]
53. [Dexrazoxane in anthracycline induced cardiotoxicity and extravasation].
Goey AK; Schellens JH; Beijnen JH; Huitema AD
Ned Tijdschr Geneeskd; 2010; 154():A1155. PubMed ID: 20619024
[TBL] [Abstract][Full Text] [Related]
54. Pro-brain natriuretic peptide is a sensitive marker for detecting cardiac metastases in patients with non-small cell lung cancer.
Lafaras C; Mandala E; Saratzis A; Platogiannis D; Barbetakis N; Papoti S; Christopoulou M; Ilonidis G; Bischiniotis T
Onkologie; 2009 Jul; 32(7):389-92. PubMed ID: 19556815
[TBL] [Abstract][Full Text] [Related]
55. Biomarker approach to the detection and cardioprotective strategies during anthracycline chemotherapy.
Ky B; Carver JR
Heart Fail Clin; 2011 Jul; 7(3):323-31. PubMed ID: 21749884
[TBL] [Abstract][Full Text] [Related]
56. Cardiac Troponin I Predicts Elevated B-type Natriuretic Peptide in Patients Treated with Anthracycline-Containing Chemotherapy.
Oikawa M; Yoshihisa A; Yokokawa T; Misaka T; Yaegashi D; Miyata M; Nakazato K; Ishida T; Takeishi Y
Oncology; 2020; 98(9):653-660. PubMed ID: 32454480
[TBL] [Abstract][Full Text] [Related]
57. The value of left ventricular global longitudinal strain assessed by three-dimensional strain imaging in the early detection of anthracyclinemediated cardiotoxicity.
Mornoş C; Manolis AJ; Cozma D; Kouremenos N; Zacharopoulou I; Ionac A
Hellenic J Cardiol; 2014; 55(3):235-44. PubMed ID: 24862616
[TBL] [Abstract][Full Text] [Related]
58. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T.
McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
Eur Heart J; 2008 Dec; 29(23):2843-50. PubMed ID: 18682444
[TBL] [Abstract][Full Text] [Related]
59. Anthracycline-induced cardiotoxicity in diffuse large B-cell lymphoma: NT-proBNP and cardiovascular score for risk stratification.
Ferraro MP; Gimeno-Vazquez E; Subirana I; Gómez M; Díaz J; Sánchez-González B; García-Pallarols F; Martínez L; Ble M; Molina L; Belarte LC; Abella E; Elosua R; Comín-Colet J; Salar A
Eur J Haematol; 2019 Jun; 102(6):509-515. PubMed ID: 30972815
[TBL] [Abstract][Full Text] [Related]
60. Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia.
Ruggiero A; De Rosa G; Rizzo D; Leo A; Maurizi P; De Nisco A; Vendittelli F; Zuppi C; Mordente A; Riccardi R
Int J Clin Oncol; 2013 Oct; 18(5):927-33. PubMed ID: 22911020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
